Australia markets open in 3 hours 31 minutes

Abiomed, Inc. (ABMD)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
281.42+2.92 (+1.05%)
At close: 4:00PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 512.68B
Enterprise value 312.26B
Trailing P/E 81.03
Forward P/E 153.20
PEG ratio (5-yr expected) 12.62
Price/sales (ttm)15.88
Price/book (mrq)11.50
Enterprise value/revenue 315.36
Enterprise value/EBITDA 650.07

Trading information

Stock price history

Beta (5Y monthly) 1.17
52-week change 353.02%
S&P500 52-week change 314.01%
52-week high 3319.19
52-week low 3119.01
50-day moving average 3272.76
200-day moving average 3251.97

Share statistics

Avg vol (3-month) 3304.96k
Avg vol (10-day) 3233.76k
Shares outstanding 545.05M
Float 44.04M
% held by insiders 12.04%
% held by institutions 1101.37%
Shares short (29 Sep 2020) 42.57M
Short ratio (29 Sep 2020) 47.83
Short % of float (29 Sep 2020) 46.54%
Short % of shares outstanding (29 Sep 2020) 45.70%
Shares short (prior month 30 Aug 2020) 42.15M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 301 Oct 2000

Financial highlights

Fiscal year

Fiscal year ends 30 Mar 2020
Most-recent quarter (mrq)29 Jun 2020


Profit margin 19.88%
Operating margin (ttm)27.98%

Management effectiveness

Return on assets (ttm)11.76%
Return on equity (ttm)15.08%

Income statement

Revenue (ttm)798.07M
Revenue per share (ttm)17.68
Quarterly revenue growth (yoy)-20.60%
Gross profit (ttm)689.58M
EBITDA 244.88M
Net income avi to common (ttm)158.67M
Diluted EPS (ttm)3.47
Quarterly earnings growth (yoy)-49.90%

Balance sheet

Total cash (mrq)427.36M
Total cash per share (mrq)9.49
Total debt (mrq)12.12M
Total debt/equity (mrq)1.10
Current ratio (mrq)5.61
Book value per share (mrq)24.46

Cash flow statement

Operating cash flow (ttm)282.05M
Levered free cash flow (ttm)162.46M